Wa Univ Sch Med Company Profile
What is the competitive landscape for WA UNIV SCH MED
WA UNIV SCH MED has two approved drugs.
Drugs and US Patents for Wa Univ Sch Med
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wa Univ Sch Med | CHOLINE C-11 | choline c-11 | INJECTABLE;INTRAVENOUS | 208413-001 | Jan 10, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wa Univ Sch Med | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204506-002 | Feb 13, 2026 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wa Univ Sch Med | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204506-001 | Feb 7, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

